PDS BiotechnologyPDSB
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 47 institutions reported holding PDS Biotechnology Corp. (PDSB) in their 13F filings, down 8 from Q2 2025. 8 opened new positions and 15 sold out. The largest holders were Vanguard Group Inc. ($1.9M), Inspirion Wealth Advisors, LLC ($1.3M) and BlackRock, Inc. ($523K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- PDS Biotechnology Corp.
- CUSIP
- 70465T107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $213K |
| Exits | 15 | $3.3M |
All 13F filers, Q2 2025 → Q3 2025: 1,132,579 shares bought and 2,950,276 shares sold, net −1,817,697 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Vanguard Group Inc. | 0.00% | Reduce -2.6% | 1,901,441 | $1.9M |
| Inspirion Wealth Advisors, LLC | 0.18% | Add +338.5% | 344,394 | $1.3M |
| BlackRock, Inc. | 0.00% | Add +0.6% | 517,519 | $523K |
| Geode Capital Management, LLC | 0.00% | Add +15.3% | 481,999 | $487K |
| Citadel Advisors | 0.00% | Add +55.2% | 386,430 | $390K |
| Squarepoint Ops LLC | 0.00% | Add +198.3% | 291,627 | $295K |
| Renaissance Technologies | 0.00% | Add +161.0% | 275,861 | $279K |
| Blair William & Co. | 0.00% | No change | 250,000 | $253K |
| UBS Group AG | 0.00% | Reduce -63.1% | 200,236 | $202K |
| State Street Corp. | 0.00% | No change | 133,333 | $135K |
| Northern Trust Corp. | 0.00% | Reduce -7.2% | 113,472 | $115K |
| Susquehanna International Group, LLP | 0.00% | Add +603.7% | 94,344 | $95K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -0.2% | 90,497 | $91K |
| Iron Gate Global Advisors LLC | 0.01% | New | 75,016 | $77K |
| Acadian Asset Management LLC | 0.00% | New | 61,793 | $61K |
| Watts Gwilliam & Co., LLC | 0.01% | No change | 55,000 | $56K |
| Tempus Wealth Planning, LLC | 0.01% | No change | 47,800 | $48K |
| Jane Street Group, LLC | 0.00% | Reduce -47.2% | 36,581 | $37K |
| Rockefeller Capital Management L.P. | 0.00% | New | 34,467 | $35K |
| Bank of New York Mellon Corp | 0.00% | No change | 29,293 | $30K |
| XTX Topco Ltd | 0.00% | New | 19,699 | $20K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 18,800 | $19K |
| Dimensional Fund Advisors LP | 0.00% | No change | 18,382 | $19K |
| First Manhattan Co. Llc. | 0.00% | No change | 15,000 | $15K |
| Two Sigma Securities, LLC | 0.00% | Reduce -37.5% | 14,149 | $14K |
| Raymond James Financial Inc. | 0.00% | Reduce -0.6% | 13,776 | $14K |
| Mercer Global Advisors Inc. | 0.00% | Reduce -0.1% | 12,500 | $13K |
| Simplex Trading, LLC | 0.00% | New | 12,405 | $12K |
| Stratos Wealth Partners, LTD. | 0.00% | No change | 11,303 | $11K |
| Burns J W & Co. Inc. | 0.00% | No change | 10,300 | $10K |
| Grandfield & Dodd, LLC | 0.00% | No change | 10,000 | $10K |
| Morgan Stanley | 0.00% | Add +11.1% | 8,259 | $8K |
| Kathleen S. Wright Associates Inc. | 0.00% | No change | 7,000 | $7K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 10,528 | $7K |
| Wells Fargo & Company | 0.00% | No change | 5,329 | $5K |
| Creative Financial Designs Inc. | 0.00% | No change | 3,000 | $3K |
| Jones Financial Companies LLLP | 0.00% | New | 2,000 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -73.9% | 1,863 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -0.2% | 1,136 | $1K |
| Bank of America Corp. | 0.00% | Add +60.0% | 1,037 | $1K |
| FMR LLC | 0.00% | Reduce -1.9% | 1,006 | $1K |
| Truvestments Capital LLC | 0.00% | Reduce -41.0% | 655 | $662 |
| JPMorgan Chase & Co. | 0.00% | No change | 619 | $625 |
| Rialto Wealth Management, LLC | 0.00% | No change | 400 | $404 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -46.9% | 110 | $111 |
| Citigroup Inc. | 0.00% | New | 24 | $24 |
| Osaic Holdings, Inc. | 0.00% | Reduce -96.7% | 17 | $17 |
"% of holder's portfolio" is PDSB's weight in each manager's 13F, not the share of PDS Biotechnology Corp. the manager owns.